Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ADUS
ADUS logo

ADUS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Addus Homecare Corp (ADUS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
93.150
1 Day change
-0.37%
52 Week Range
124.440
Analysis Updated At
2026/04/02
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Addus HomeCare Corp (ADUS) is currently not a strong buy for a beginner investor with a long-term focus. While the company has demonstrated strong financial growth in its latest quarter, the technical indicators suggest a bearish trend, and there is no significant positive catalyst or trading signal to support immediate action. Holding off for a better entry point or further confirmation of trend reversal is recommended.

Technical Analysis

The stock is in a bearish trend with MACD negatively expanding (-0.589), RSI indicating oversold conditions (9.817), and moving averages showing bearish alignment (SMA_200 > SMA_20 > SMA_5). Current price is below key support levels (S1: 92.485, S2: 89.92).

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
4

Positive Catalysts

  • Strong financial performance in Q4 2025, with revenue up 25.55% YoY, net income up 52.52% YoY, and EPS up 50.47% YoY.

Neutral/Negative Catalysts

  • Bearish technical indicators, lack of recent positive news, and analysts lowering price targets (e.g., Barclays reducing target to $102).

Financial Performance

In Q4 2025, revenue increased to $373.08M (+25.55% YoY), net income rose to $29.78M (+52.52% YoY), and EPS grew to 1.61 (+50.47% YoY). However, gross margin dropped to 32.02% (-3.18% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Mixed ratings with Barclays maintaining an Underweight rating and lowering price targets to $102 and $112, while Stephens and Truist analysts maintain higher targets ($135) with Overweight and Buy ratings, respectively.

Wall Street analysts forecast ADUS stock price to rise
5 Analyst Rating
Wall Street analysts forecast ADUS stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 93.500
sliders
Low
120
Averages
135.25
High
147
Current: 93.500
sliders
Low
120
Averages
135.25
High
147
Barclays
Underweight
downgrade
$112 -> $102
AI Analysis
2026-03-25
Reason
Barclays
Price Target
$112 -> $102
AI Analysis
2026-03-25
downgrade
Underweight
Reason
Barclays lowered the firm's price target on Addus HomeCare to $102 from $112 and keeps an Underweight rating on the shares. The firm revised models in the healthcare facilities and managed care group following the Q4 reports.
Stephens
Scott Fidel
Overweight
maintain
$140 -> $135
2026-02-25
Reason
Stephens
Scott Fidel
Price Target
$140 -> $135
2026-02-25
maintain
Overweight
Reason
Stephens analyst Scott Fidel lowered the firm's price target on Addus HomeCare to $135 from $140 and keeps an Overweight rating on the shares. The firm trimmed out-year estimates following the company's Q4 report, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ADUS
Unlock Now

People Also Watch